A detailed history of American Century Companies Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 738,495 shares of REGN stock, worth $528 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
738,495
Previous 825,832 10.58%
Holding current value
$528 Million
Previous $868 Million 10.56%
% of portfolio
0.46%
Previous 0.54%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1024.09 - $1201.76 $89.4 Million - $105 Million
-87,337 Reduced 10.58%
738,495 $776 Million
Q2 2024

Aug 07, 2024

SELL
$883.2 - $1071.19 $49.5 Million - $60.1 Million
-56,073 Reduced 6.36%
825,832 $868 Million
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $44.6 Million - $49.1 Million
-49,423 Reduced 5.31%
881,905 $849 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $722 Million - $821 Million
931,328 New
931,328 $818 Million
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $20.8 Million - $25.4 Million
30,050 Added 3.39%
916,718 $754 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $52.5 Million - $62.3 Million
-75,042 Reduced 7.8%
886,668 $637 Million
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $95.5 Million - $116 Million
-140,292 Reduced 12.73%
961,710 $790 Million
Q4 2022

Feb 13, 2023

SELL
$705.89 - $766.39 $53.7 Million - $58.3 Million
-76,069 Reduced 6.46%
1,102,002 $795 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $771,989 - $974,210
1,345 Added 0.11%
1,178,071 $812 Million
Q2 2022

Aug 12, 2022

BUY
$548.35 - $738.84 $40.8 Million - $55 Million
74,420 Added 6.75%
1,176,726 $696 Million
Q1 2022

May 11, 2022

BUY
$595.12 - $698.43 $22.2 Million - $26.1 Million
37,370 Added 3.51%
1,102,306 $770 Million
Q4 2021

Feb 07, 2022

SELL
$543.48 - $670.97 $59.6 Million - $73.6 Million
-109,728 Reduced 9.34%
1,064,936 $673 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $11.2 Million - $13.3 Million
19,591 Added 1.7%
1,174,664 $711 Million
Q2 2021

Aug 05, 2021

BUY
$472.8 - $558.54 $23.8 Million - $28.1 Million
50,312 Added 4.55%
1,155,073 $645 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $79.8 Million - $98 Million
178,725 Added 19.3%
1,104,761 $523 Million
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $1.8 Million - $2.29 Million
-3,768 Reduced 0.41%
926,036 $447 Million
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $17.1 Million - $20.6 Million
31,333 Added 3.49%
929,804 $520 Million
Q2 2020

Aug 13, 2020

SELL
$493.32 - $643.92 $36.6 Million - $47.8 Million
-74,292 Reduced 7.64%
898,471 $560 Million
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $12.3 Million - $18.1 Million
-36,672 Reduced 3.63%
972,763 $475 Million
Q4 2019

Feb 12, 2020

BUY
$274.13 - $376.51 $18 Million - $24.7 Million
65,515 Added 6.94%
1,009,435 $379 Million
Q3 2019

Nov 13, 2019

SELL
$273.46 - $318.39 $24.1 Million - $28 Million
-88,094 Reduced 8.54%
943,920 $262 Million
Q2 2019

Aug 14, 2019

SELL
$299.6 - $414.82 $2.71 Million - $3.75 Million
-9,030 Reduced 0.87%
1,032,014 $323 Million
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $14 Million - $16.5 Million
37,573 Added 3.74%
1,041,044 $0
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $47.9 Million - $57.5 Million
142,779 Added 16.59%
1,003,471 $375 Million
Q3 2018

Nov 02, 2018

SELL
$351.14 - $408.51 $18.1 Million - $21 Million
-51,436 Reduced 5.64%
860,692 $348 Million
Q2 2018

Aug 08, 2018

SELL
$284.6 - $344.99 $12.8 Million - $15.5 Million
-45,061 Reduced 4.71%
912,128 $315 Million
Q1 2018

May 03, 2018

BUY
$315.82 - $393.78 $25.1 Million - $31.3 Million
79,602 Added 9.07%
957,189 $330 Million
Q4 2017

Feb 02, 2018

SELL
$358.63 - $469.95 $14.3 Million - $18.8 Million
-39,967 Reduced 4.36%
877,587 $330 Million
Q3 2017

Nov 01, 2017

BUY
$431.38 - $504.0 $396 Million - $462 Million
917,554
917,554 $410 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.